827 related articles for article (PubMed ID: 32153386)
1. CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.
Lopes-Pacheco M
Front Pharmacol; 2019; 10():1662. PubMed ID: 32153386
[TBL] [Abstract][Full Text] [Related]
2. CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis.
Lopes-Pacheco M
Front Pharmacol; 2016; 7():275. PubMed ID: 27656143
[TBL] [Abstract][Full Text] [Related]
3. Discovery of CFTR modulators for the treatment of cystic fibrosis.
Lopes-Pacheco M; Pedemonte N; Veit G
Expert Opin Drug Discov; 2021 Aug; 16(8):897-913. PubMed ID: 33823716
[TBL] [Abstract][Full Text] [Related]
4. Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis.
Cuyx S; De Boeck K
Semin Respir Crit Care Med; 2019 Dec; 40(6):762-774. PubMed ID: 31659727
[TBL] [Abstract][Full Text] [Related]
5. One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.
Ensinck MM; Carlon MS
Cells; 2022 Jun; 11(12):. PubMed ID: 35740997
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis.
Burgener EB; Moss RB
Curr Opin Pediatr; 2018 Jun; 30(3):372-377. PubMed ID: 29538046
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Modulation of Ion Channels for the Treatment of Cystic Fibrosis.
Pinto MC; Silva IAL; Figueira MF; Amaral MD; Lopes-Pacheco M
J Exp Pharmacol; 2021; 13():693-723. PubMed ID: 34326672
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of cystic fibrosis: from bench to bedside.
Dechecchi MC; Tamanini A; Cabrini G
Ann Transl Med; 2018 Sep; 6(17):334. PubMed ID: 30306073
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.
Solomon GM; Marshall SG; Ramsey BW; Rowe SM
Pediatr Pulmonol; 2015 Oct; 50 Suppl 40(0 40):S3-S13. PubMed ID: 26097168
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives.
Schmidt BZ; Haaf JB; Leal T; Noel S
Clin Pharmacol; 2016; 8():127-140. PubMed ID: 27703398
[TBL] [Abstract][Full Text] [Related]
11. Advancing clinical development pathways for new CFTR modulators in cystic fibrosis.
Mayer-Hamblett N; Boyle M; VanDevanter D
Thorax; 2016 May; 71(5):454-61. PubMed ID: 26903594
[TBL] [Abstract][Full Text] [Related]
12. CFTR Modulator Therapy and Its Impact on Lung Transplantation in Cystic Fibrosis.
Benden C; Schwarz C
Pulm Ther; 2021 Dec; 7(2):377-393. PubMed ID: 34406641
[TBL] [Abstract][Full Text] [Related]
13. Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator.
Merk D; Schubert-Zsilavecz M
Expert Opin Drug Discov; 2013 Jun; 8(6):691-708. PubMed ID: 23574506
[TBL] [Abstract][Full Text] [Related]
14. State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (
Meoli A; Fainardi V; Deolmi M; Chiopris G; Marinelli F; Caminiti C; Esposito S; Pisi G
Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577628
[TBL] [Abstract][Full Text] [Related]
15. Innovative Therapies for Cystic Fibrosis: The Road from Treatment to Cure.
Cabrini G
Mol Diagn Ther; 2019 Apr; 23(2):263-279. PubMed ID: 30478715
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
Arora K; Naren AP
Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
[TBL] [Abstract][Full Text] [Related]
17. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls.
Bell SC; De Boeck K; Amaral MD
Pharmacol Ther; 2015 Jan; 145():19-34. PubMed ID: 24932877
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of cystic fibrosis treatment.
Carter SC; McKone EF
Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
[TBL] [Abstract][Full Text] [Related]
19. F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
Yang H; Ma T
Expert Opin Ther Pat; 2015; 25(9):991-1002. PubMed ID: 25971311
[TBL] [Abstract][Full Text] [Related]
20. Recent Progress in the Discovery and Development of Small-Molecule Modulators of CFTR.
Kym PR; Wang X; Pizzonero M; Van der Plas SE
Prog Med Chem; 2018; 57(1):235-276. PubMed ID: 29680149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
